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Abstract Objectives: Coronary artery bypass surgery (CABG) using conventionally
harvested saphenous vein (SV) as a graft is characterised by a high graft failure
rate. It is believed that vein handling during harvesting is responsible for this, as
damage to the vein’s structure including its sources of endothelial nitric oxide
synthase (eNOS) is apparent. Here we investigated the distribution of inducible
nitric oxide synthase (iNOS) in conventionally harvested SV grafts and grafts pre-
pared by a less-invasive ‘no-touch’ technique for CABG. Focus was on vascular
smooth muscle cells (VSMCs).
Patients and methods: Six patients undergoing CABG were selected for the study;
their SVs were harvested as grafts by conventional and ‘no-touch’ techniques and
subsequently examined using fluorescent and transmission electron microscopy
combined with immunolabelling to detect iNOS and structural changes in the grafts
at the time of implantation.
Results: The following were observed in conventionally harvested grafts: (i) dam-
age to the VSMCs and (ii) induction of iNOS in these cells, (iii) heterogeneity of
VSMCsdthe presence of iNOS-positive and iNOS-negative VSMCs which were also
(iv) in close contact with each other. In contrast, no damage to VSMCs and no
expression of iNOS in these cells were observed in the ‘no-touch’ SV prepara-
tions.
* Corresponding author. Tel.: þ44 020 7794 0500X5374; fax: þ44 020 7472 6763.
E-mail address: a.loesch@medsch.ucl.ac.uk (A. Loesch).1743-9191/$ - see front matter ª 2005 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijsu.2005.11.002
Localisation of iNOS in human saphenous vein for CABG 21Conclusions: The harvesting procedure influences the structure of VSMCs and the
expression of iNOS in SV graft at the time of implantation. Whether rapid stim-
ulation of iNOS in VSMCs in conventional SV grafts has a protective or harmful
effect on the graft patency remains to be determined.
ª 2005 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
The human saphenous vein (SV), when harvested
conventionally for coronary artery bypass grafting
(CABG), is stripped of surrounding connective tissue
including the adventitia; this provokes the vein to
go into spasm, and to overcome this the SV is
distended prior to grafting.1e3 Failure of grafts har-
vested this way is relatively high, with 10e20% of
grafts occluding within the first year and over 50%
within 10 years.4,5 These conventional harvesting
procedures induce ultrastructural changes in SV
grafts3,6,7 including alterations in vascular smooth
muscle cells (VSMCs).8 Conventional harvesting
also removes substantial sources of endothelial
nitric oxide synthase (eNOS) and hence nitric oxide
(NO) due to damage and loss of the endothelium
and the vasa vasorum.9e12 It has been observed
that reduced manual manipulation of grafts during
venous or arterial surgery (‘dissection without
touching’) results in better preservation of the en-
dothelium.2 One further improvement in harvesting
has been described, a ‘no-touch’ technique, which
minimises mechanical trauma to SVs used for CABG,
by conserving the surrounding connective tissue
and not distending the vein.3 This less invasive har-
vesting technique improves the outcome of CABG
and increases both early and long term patency
rates of SV grafts.13,14 Recent results of 8.5 years
follow-up angiographic and intravascular ultra-
sound (IVUS) studies have shown higher patency
rates of ‘no-touch’ SV grafts, 92%, versus 78% for
conventionally harvested grafts.14 To minimise
venous graft failure, a broader acceptance of the
‘no-touch’ technique for CABG surgery has now
been recommended.15
Using fluorescence and transmission electron
microscopy combined with immunolabelling we
have focused on the distribution of inducible nitric
oxide synthase (iNOS) and the structure of VSMCs
in ‘no-touch’ (normal) and conventionally har-
vested SV used in patients undergoing CABG.
Patients and methods
Patients: clinical data
Samples of SV were obtained from six patients,
two women and four men, 54e70 years of age,undergoing CABG surgery at the Department of
Cardiothoracic Surgery, O¨rebro University Hospi-
tal, O¨rebro, Sweden. Ethical approval and pa-
tients’ informed consent were obtained for the
study. The patients were selected to represent as
closely as possible the same medical history and
conditions. The patients were free of diabetes,
suffered from angina and heart failure NYHA class
III; they were smokers and were receiving aspirin
and beta-blockers before surgery.
SV samples
During CABG surgery a proximal segment of the SV
was harvested (within 1 h) with its surrounding
adventitia and peri/paravascular connective tissue
using the ‘no-touch’ technique.3 Adjacent seg-
ments were stripped of surrounding tissue and
adventitia, and distended with saline at a pressure
of 300 mmHg for 1 min using a syringe connected
to a manometerdthe conventional technique.
Both SV segments were stored for about 30 min
at room temperature in heparinised patient’s
blood (obtained from the aortic cannula) before
implantation.16 Samples of excess SV grafts were
taken from the two (conventional and ‘no-touch’)
segments on completion of the proximal anasta-
mosis and processed for fluorescence-immunohis-
tochemistry and electron-immunocytochemistry.
Fluorescence-immunohistochemistry
To examine the general aspects of iNOS distribu-
tion, samples from excess SV segments were fast
frozen and stored at 70 C. Using a Reichert-Jung
CM1800 cryostat, specimens were then cross-sec-
tioned at 15 mm and collected onto polylysine-coated
microscope slides for the immunoprocedure. In
brief, sections were (i) washed in 0.1 M phos-
phate-buffered saline (PBS), (ii) placed for 1 h in
10% non-immune normal horse serum (Jackson
ImmunoResearch Laboratories West-Grave, PA,
USA) in PBS containing 0.1% sodium azide, (iii) incu-
bated for 24 h at 8 C with a polyclonal antibody to
iNOS at a dilution of 1:200 in PBS (containing 10%
non-immune normal horse serum and 0.1% sodium
azide), (iv) washed in PBS, (v) incubated for 1 h
with biotin-conjugated donkey anti-rabbit IgG
serum (Jackson) diluted 1:500 in PBS, (vi) washed
22 A. Loesch et al.in PBS, (vii) exposed for 1 h to Streptavidin-Texas
red (Amersham, Biosciences, Little Chalfont, UK)
diluted 1:200 in PBS. Sections were then washed
in PBS and mounted in Citifluor (Citifluor Ltd., Lon-
don, UK) for examination with a Zeiss Axioplan fluo-
rescence microscope (Zeiss, Germany) with a Leica
DC200 digital camera. Fluorescence filters (568 ex-
citation line) allowed observation of labelling with
Texas red; objective lenses with 10 and 20 (dry
aperture) and 40 and 63 (oil immersion) were
used for examination of the specimens. Images
were stored digitally.
Electron-immunocytochemistry
For ultrastructural purposes, samples of SV were
fixed overnight at 4 C by immersion in fixative
consisting of 4% paraformaldehyde and 0.2% glutaral-
dehyde in 0.1 M phosphate buffer (pH 7.4). After
fixation, SV were transferred to 0.1 M phosphate
buffer containing 0.1% sodium azide, cross-sectioned
at ~100 mm using a vibratome, collected in 0.1 M Tris
buffered-saline (TBS), at pH 7.6, and processed for
the pre-embedding ExtrAvidin immunocytochemical
method. In brief, sections were (a) exposed to 0.3%
hydrogen peroxide in 33% ethanol for 45 min (in order
to block endogenous peroxidases), (b) washed in TBS,
(c) placed for 1 h in 10% non-immune normal horse
serum, (d) washed in TBS, (e) incubated for 24 h at
8 C with a polyclonal antibody to iNOS (as above)
at a dilution of 1:400 in TBS containing 10% non-
immune normal horse serum and 0.1% sodium azide,
(f) washed in TBS, (g) incubated for 16 h at 8 C
with biotin-conjugated donkey anti-rabbit IgG serum
(Jackson) diluted 1:500 in TBS containing 1% non-
immune normal horse serum and 0.1% sodium azide,
(g) washed in TBS, (h) exposed for 5 h at 8 C to
ExtrAvidin-horseradish peroxidase conjugate (Sigma,
Poole, UK) diluted 1:1500 in TBS, and then (i) washed
in TBS. Immunoreactivity was visualised with diami-
nobenzidine (Sigma). After extensive rinsing in TBS
and distilled water, sections were placed in 1% osmi-
um tetroxide in 0.1 M sodium cacodylate buffer for
1 h (at 4 C), and then washed in sodium cacodylate
buffer, dehydrated in a graded series of ethanol and
propylene oxide, flat embedded in Araldite and poly-
merised. Ultrathin sections were stained with uranyl
acetate and lead citrate, and subsequently examined
and photographed using either a JEOL-1010 or Philips
CM-120 transmission electron microscope.
Immunocytochemical controls
Rabbit polyclonal anti-human iNOS antibody (SC-
651) (directed against an N-terminal peptide (ami-
no acids 3e22) of human iNOS) was manufacturedand characterised by Santa Cruz Biotechnology
(Santa Cruz, CA). The antibody specifically detects
iNOS and does not cross-react with human eNOS or
nNOS. In the present study, the routine omission of
the iNOS antibody and IgG steps, independently,
resulted in a lack of immunolabelling; these con-
trols were performed both at the light (fluores-
cence) and electron microscopic levels.
Results
General features of SV segments harvested by the
‘no-touch’ and conventional techniques are dia-
grammatically summarised in Fig. 1; these features
apply to all the ‘no-touch’ and conventional prepa-
rations, respectively, examined in this study.
‘No-touch’ SV retained a normal architecture;
a cushion of surrounding connective tissue was pre-
served, and the luminal folds were present
(Fig. 1a). In contrast, in SV harvested conventionally,
the cushion of connective tissue was removed and
the vein was distended. There was thinning of the
media and dilation of the lumen caused by
distension (Fig. 1b).
Fluorescence-immunohistochemistry
Immunoreactivity for iNOS was seen in the tunica
media of all segments of conventionally harvested
SV examined (Fig. 2aec), whilst the media of both
‘no-touch’ and the immunocytochemical control
SV specimens were essentially free of iNOS immu-
noreactivity (Fig. 2d,e). Immunoreactivity for iNOS
was mostly located in the cells of the media
(Fig. 2b). Also cells located at the edges of the
SV wall, where the adventitia had been removed,
displayed strong labelling for iNOS (Fig. 2c). Varia-
tions in shape and size of the labelled cells were
noticeable.
Electron-immunocytochemistry
Electron microscopic examination revealed
changes throughout the tunica media of all seg-
ments of conventionally harvested SV as compared
with those harvested using the ‘no-touch’ tech-
nique. The VSMCs displayed polymorphism where
a number of cells contained vacuoles of various
sizes, some of which occupied a substantial part of
the cell cytoplasm. Under immunocytochemical
investigation these vacuolated VSMCs showed im-
munoreactivity for iNOS (Fig. 3a). The immunore-
activity was associated with the cytoplasm,
whilst no immunolabelling was observed within
Localisation of iNOS in human saphenous vein for CABG 23Figure 1 General diagram of the structure of ‘no-touch’ (a) and conventional (b) SV grafts for CABG examined in this
study. In (a) note the presence of a pronounced pedicle of peri/paravascular connective tissue including adventitia and
the existence of intimal folds projecting from the lumen into tunica media. In (b) note a drastic change in the vein’s
appearance. The wall is thin; the pedicle of connective tissue is absent due to its removal during harvesting; also absent
are the intimal folds due to the vein distension (with saline at a pressure of 300 mmHg for 1 min). Bar: 1 mm.intracellular vacuoles, which were electron-
transparent. Vacuolated and non-vacuolated me-
dial VSMCs were also present close to the edge of
the SV wall, where the adventitia had been re-
moved during harvesting. These cells were either
positive or negative for iNOS (Fig. 3b). Regardless
of the region of the tunica media in which iNOS-
positive VSMCs were present, these cells showed
cytoplasmic disorders. It was not uncommon in
the tunica media to observe neighbouring undam-
aged iNOS-negative VSMCs and damaged iNOS-pos-
itive cells. Features common to conventionally
harvested grafts were contacts established be-
tween iNOS-positive and iNOS-negative VSMCs
(Fig. 3a, inset). Some of the iNOS-negative VSMCs
engaged in cell-to-cell contacts displayed vacuo-
lated cytoplasm at the cell’s perinuclear regions.
The nuclei of the cells displayed features of mitotic
activity (Fig. 4).
Under higher electron microscopic magnifica-
tion, more precise locations of immunoprecipitate
were detected in iNOS-positive VSMCs. In particu-
lar, the location of iNOS immunoreactivity on/in
endoplasmic reticulum and strands of cytoplasm
was apparent (Fig. 5a,b). Furthermore, the caveo-
lae of the VSMC plasmalemma were immunola-
belled (Fig. 6a,b). The labelled caveolae were
also identified at the cell-to-cell contacts (Fig. 6c).
There was no evidence of iNOS immunoreactivity
in VSMCs of ‘no-touch’ preparations of SV (Fig. 7,
also see Fig. 2d); these appeared similar to negativeimmunocytochemical control preparations (not
shown). Also VSMCs of ‘no-touch’ preparations dis-
played ‘normal’ structure.
Discussion
The present study showed that segments of SV
conventionally harvested for CABG expressed
immunoreactive iNOS in VSMCs which were struc-
turally altered (damaged) and those segments
harvested with the ‘no-touch’ method, were free
of immunoreactivity and the structure of cells was
well preserved.
Previous studies of SV used for CABG showed that
conventional harvesting significantly impairs NO
activity making the graft prone to pathological
changes including stenosis after implantation.17
In fact, conventional harvesting may lead to an
almost complete abolition of NO release from the
SV graft.18 The general presence of NOS in human
SV used for CABG has been demonstrated using
NADPH-diaphorase histochemistry19 and reduced
levels of eNOS in conventional compared to ‘no-
touch’ SV has been reported using Western blot
analysis and light microscopic immunohistochemis-
try.10 The reduction in eNOS content of convention-
ally harvested SV is not surprising as the structural
damage to the vein, including its sources of NOdthe
endothelium and the vasa vasorumdis severe at
the time of implantation.7,8,11 Furthermore, pro-
gressive vascular changes, including a differential
24 A. Loesch et al.Figure 2 Fluorescence-immunolabelling of iNOS in conventional (aec) and ‘no-touch’ (d) SV grafts harvested for
CABG; (e) is an example of immunohistochemical control. (a) Note iNOS immunoreactivitydseen as intense red label-
lingdin the media (M) of conventional SV graft. I, intima; lu, lumen. Bar, 20 mm. (b) Magnified fragment of the media
shows multi-shaped iNOS-positive cells. Bar, 10 mm. (c) Note a group of iNOS-positive cells in the damaged outer
media, which is exposed to the empty space (asterisks) following removal of the adventitia. Bar, 20 mm. (d) In ‘no-
touch’ SV note lack of immunoreactivity for iNOS. Bar, 20 mm. (e) In the immunohistochemical control with omission
of primary antibody, no immunoreactivity for iNOS is observed in the conventional SV graft. Bar, 20 mm.reduction in eNOS, have been observed in explanted
aorto-coronary SV grafts coinciding with regions
of intimal hyperplasia and focal sites of
atherosclerosis.20
Role of iNOS in VSMCs
Our study showed iNOS expression in damaged
VSMCs of conventionally harvested SV at the time
of implantation. The role of iNOS from VSMCs of SVused for CABG is not clear. Both protective and
harmful effects of iNOS/NO may be considered.
One of the first studies that showed a significant
increase of iNOS gene expression in human SV used
as aorto-coronary grafts suggested that this phe-
nomenon could be linked with iNOS involvement in
graft patency.21 This study was based on failed SV
grafts available at the time of redo CABG operations
performed several years after implantation to the
coronary vascular bed. Taken together our data
Localisation of iNOS in human saphenous vein for CABG 25Figure 3 Electron-immunolabelling of conventionally harvested SV. (a) Note a group of vacuolated and non-vacuo-
lated VSMCs (sm). The vacuolated VSMCs display immunoreactivity for iNOS (black immunoprecipitate, arrows), which
is localised in the cytoplasm including that around the electron-transparent vacuoles (va); the immunonegative VSMCs
are essentially free of vacuoles. Also, an iNOS-positive VSMC contacting an iNOS-negative cell can be seen (boxed
area). CT, intercellular connective tissue. Bar, 3 mm. Inset is an enlargement of the boxed area showing a contact
between the iNOS-positive and iNOS-negative VSMCs. Bar, 0.5 mm. (b) Note a group of iNOS-positive and iNOS-negative
VSMCs in the outer media, close to the site of the removed adventitia (asterisk); note the polymorphism of iNOS-
immunoreactive VSMCs. Bar, 2 mm.and that of Dattilo et al.21 suggests that iNOS is rap-
idly induced (by mechanical trauma) in convention-
ally handled SV for coronary grafts, and that iNOS
expression in such grafts may be sustained for
months or even years. Furthermore, NO generated
by iNOS in VSMCs may compensate for the intimal
damage that occurs during harvesting, and the
loss of eNOS-derived NO from disrupted endothelial
cells. The NO generated from VSMCs by iNOS wouldtherefore be expected to restore vascular homeo-
stasis after injury,22,23 such as that inflicted to the
SV during conventional harvesting for CABG. Studies
of rat aortic allografts showed that iNOS protects
the grafts against the development of arterioscle-
rosis.24 Increased iNOS expression and hence NO
production may restrict both thrombotic and prolif-
erative responses in injured vessels,25 yet the long-
term elaboration of iNOS in SV grafts seems unable
26 A. Loesch et al.Figure 4 Electron-immunolabelling of conventionally harvested SV. Note the iNOS-positive VSMC (asterisk) contact-
ing two iNOS-negative VSMCs (sm). Also note that in the iNOS-negative VSMC the sarcoplasmic reticulum (sr) is en-
larged (vacuolated); the segregation of chromatin (Ch) in the nucleus suggests mitotic activity. Bar, 2 mm.to prevent graft failure21 despite NO being pro-
duced by VSMCs after injury and responses to cyto-
kine stimulation.22,23
There is evidence that expression of iNOS in
VSMCs (and also macrophages and foam cells) is
associated with atherosclerosis and that the activity
Figure 5 Electron-immunolabelling of conventionally
harvested SV. (a) A magnified fragment of an altered
VSMC displays immunoreactivity for iNOS on strands of
cytoplasm (Cy) and cisterns of the endoplasmic reticu-
lum (er); the ‘empty’ unlabelled matrix (mx) can also
be seen. Bar, 250 nm. (b) An enlargement of the endo-
plasmic reticulum demonstrates intracisternal accumu-
lation of iNOS. Bar, 50 nm.of iNOS, stimulated by atherosclerosis-associated
inflammatory cytokines, promotes the formation
of harmful (cytotoxic) peroxynitrite.26 A continu-
ously high activity of iNOS leading to increased
superoxide production and peroxynitrite forma-
tion27,28 might thus have further ‘negative’ effects
on graft patency.
Heterogeneity of VSMCs and iNOS expression
Our study showed that iNOS was rapidly induced in
the subpopulation of VSMCs structurally altered by
conventional handling of the SV for CABG. Thus,
both structural and immunohistochemical hetero-
geneity of VSMCs in conventionally harvested SV
was apparent; many structurally damaged VSMCs
were iNOS-positive, whilst those well preserved
were iNOS-negative. The subcellular mechanisms
of this selective induction of iNOS in VSMCs of SV
are unknown at this stage. The possibility that
distension (stretch) of the vein media (wall)
stimulates NO release from iNOS-positive VSMCs
needs to be examined in detail since it is known
that stretch stimulates eNOS and subsequent NO
release from the endothelium.29 Studies of
balloon-injured (distended) rat arteries, have
shown increased iNOS expression in VSMCs, and
raised NO output from intimal/neointimal com-
pared with medial VSMCs. Furthermore, these ele-
vated levels of NO reduced VSMC proliferation,
although the intimal appeared less sensitive to
NO than the medial cells.23 Our studies showed
the heterogeneous capability of VSMCs to express
iNOS in the early response of the vein to surgical
mechanical stress, including distension.
Localisation of iNOS in human saphenous vein for CABG 27Figure 6 Electron-immunolabelling of conventionally harvested SV; high magnification of VSMCs (sm). (a) Note clus-
tered iNOS immunoprecipitate at a plasma membrane caveolae (arrow); unlabelled caveolae (ca) can also be seen.
ex, extracellular matrix. Bar, 100 nm. (b) Note a diffuse iNOS immunoprecipitate in the vicinity of the caveolae system
(arrow). Bar, 100 nm. (c) In the centre of the image the iNOS-positive caveolae is seen at the contact area of two
VSMCs. Bar, 100 nm.Figure 7 Electron-immunolabelling of SV harvested
with ‘no-touch’ method. A fragment of tunica media dis-
plays well-preserved VSMCs; these show no immunoreac-
tivity for iNOS. Bar, 4 mm.Subcellular iNOS localisation in VSMCs
High magnification electron microscopic images of
immunolabelled VSMCs showed iNOS-immunoreac-
tivity associated with the plasmalemmal caveolae
system, the compartment of the cells that is impli-
cated in NOS activity and NO biosynthesis.30e35 In en-
dothelial cells, transient increases of intracellular
Ca2þ promotes translocation of eNOS from caveolae
to the cytosol, and subsequent NO release.31e33
Whether iNOS detected in VSMCs undergoes a similar
translocation at the caveolae is unknown. It is possi-
ble that clustered and diffuse immunoprecipitate
observed at caveolae reflects translocation of iNOS
and different states of iNOS activity.
Contacts between iNOS-positive and
iNOS-negative VSMCs
Another striking finding, that may be relevant to
the expression of iNOS and the protective function
28 A. Loesch et al.of NO, is the existence of contacts between iNOS-
positive and iNOS-negative VSMCs. As a protective
feature, such contacts would be expected to
facilitate the inhibitory property of NO on neigh-
bouring VSMC mitogenesis, proliferation and migra-
tion and thus on NO-inhibition of intimal hyperplasia
and atherosclerosis.36e38 However, raised NO avail-
ability may also promote superoxide generation
and VSMC growth.39 We have recently shown pro-
liferation of intimal VSMCs in conventionally har-
vested SV40 in agreement with ultrastructural
findings.8 A study of the dog SV graft to femoral ar-
tery revealed early remodelling of the vein graft in
which, alongside mitogenesis and proliferation,
cell apoptosis in the media and adventitia were re-
ported.41 Features of apoptosis of VSMCs in con-
ventionally harvested SV are supported by
ultrastructural observations.8 Whether contacts
between iNOS-positive and iNOS-negative VSMCs
observed in this study have any role in
up-regulation of iNOS/NO to influence, e.g. tissue
repair42 or suppress iNOS,43 is unknown at this
stage. There is considerable complexity of the reg-
ulation of iNOS in human VSMCs.44 NO involvement
in venous reactivity may have particular signifi-
cance during pathophysiological circumstances or
mechanical damage such as inflicted during CABG.
Conclusions
The conventional harvesting of SV for CABG rapidly
stimulates the expression of iNOS in VSMCs, which
are structurally altered by harvesting. It is therefore
concluded that harvesting techniques influence the
structure of VSMCs and the expression of iNOS in the
SV graft at the time of implantation. Whether this
has beneficial or harmful effects in conventional SV
as coronary graft remains open for discussion.
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